| 000 | 01189 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250518100932.0 | ||
| 264 | 0 | _c20200501 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1866-0452 | ||
| 024 | 7 |
_a10.3238/arztebl.2020.0213 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStahlmann, Ralf | |
| 245 | 0 | 0 |
_aMedication for COVID-19-an Overview of Approaches Currently Under Study. _h[electronic resource] |
| 260 |
_bDeutsches Arzteblatt international _c03 2020 |
||
| 300 |
_a213-219 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBetacoronavirus |
| 650 | 0 | 4 | _aCOVID-19 |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xstatistics & numerical data |
| 650 | 0 | 4 |
_aCoronavirus Infections _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Development _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPandemics |
| 650 | 0 | 4 |
_aPneumonia, Viral _xdrug therapy |
| 650 | 0 | 4 | _aSARS-CoV-2 |
| 700 | 1 | _aLode, Hartmut | |
| 773 | 0 |
_tDeutsches Arzteblatt international _gvol. 117 _gno. 13 _gp. 213-219 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3238/arztebl.2020.0213 _zAvailable from publisher's website |
| 999 |
_c30909616 _d30909616 |
||